Skip to content
Home page - Centenary Institute Centenary Institute

Primary menu

  • Research
        • Research

          The latest medical research into our most complex health challenges across biomedical AI, cancer, cardiovascular diseases, immunity, age-related, rare and infectious diseases.

          Learn more

        • Biomedical AI
        • Cancer Innovations
        • Cardiovascular Research
        • Infection & Immunity
        • Rare Diseases & Gene Therapy
        • Laboratories
        • Impact
        • Technologies
        • Commercialisation
  • Support us
        • Support us

          By supporting the Centenary Institute you can help improve human health through excellence in medical research.

          Learn more

        • Workplace giving
        • Host or join a fundraiser
        • Gift in your will
        • Donate in memory
        • Advise on our research
  • Careers & students
        • Careers & Students

          Postdoctoral and postgraduate students can work alongside world-leading medical researchers within state-of-the-art research facilities.

        • Careers
        • Study opportunities
  • News & events
        • News & Events

          Explore the latest research breakthroughs and ways you can take part in our series of digital and in-person events.

        • News
        • Statements
        • Events
        • Real stories
  • About us
        • About us

          We are world-leading independent medical research institute that drives collaboration to accelerate and translate solutions to our most complex health challenges.

          Learn more

        • Governance
        • Corporate information
        • Annual reports
        • Animals in research
        • Contact
  • Donate
    Centenary Institute > News > Uncovering the causes of Alzheimer’s disease

Uncovering the causes of Alzheimer’s disease

Date time 21 February, 2018

Congratulations to Centenary’s Associate Professor Anthony Don, who is uncovering the causes of Alzheimer’s disease- the second leading cause of death in Australia

It is estimated that 425,416 Australians are currently living with Alzheimer’s disease. Dementia is the second leading cause of death of Australians, and the leading cause of death for women in this country. With our ageing population, Alzheimer’s, which is the most common form of dementia, has been identified as a national health priority. There is currently no known cure or effective treatment to halt this devastating disease.

At Centenary Institute, Associate Professor Anthony Don and research fellow Dr Tim Couttas are working towards uncovering the causes and mechanisms of this disease, with his most recent work, published in the Journal of Alzheimer’s Disease. Work towards better understanding Alzheimer’s will lead to preventing, treating and possibly curing this disease.

Scientists looked at hippocampus tissue from people aged 65 and older, who were cognitively normal at the time of death. The hippocampus is a structure in the brain that is very heavily affected in Alzheimer’s disease and is required for memory consolidation.

Scientists wanted to identify how genetic variants in the APOE gene, which is the major risk gene for Alzheimer’s, affects lipid levels in the brains of elderly, cognitively normal people. It wasn’t the APOE gene that provided the most valuable clues in the end, but scientists did find that certain lipids increase with age in the male hippocampus, and one very important lipid decreases with age in females. This could provide clues as to why the female brain is more susceptible to this disease.

“The lipid that goes down with ageing in female brains is the one I am most interested in. It is called S1P and we have previously shown that S1P is lost from affected brain regions early in the development of Alzheimer’s disease (females are more susceptible to Alzheimer’s disease). S1P is important for protecting the brain, including protecting the electrical insulation around nerve cells called myelin. I suspect the loss of S1P with ageing in females might sensitize to developing Alzheimer’s disease. Its loss may be related to loss of estrogen with ageing,” says Associate Professor Don.

This ongoing work provides important pieces to the larger jigsaw of understanding this disease. Scientists around the globe are working hard to be able to provide some hope for patients and loved ones affected by this terrible, debilitating and ultimately deadly disease.

Media enquires

For all media and interview enquiries, please contact Tony Crawshaw

Phone number Phone Number +61 402 770 403

Email Email t.crawshaw@centenary.org.au

Recent Stories

  • New grant targets longer-lasting islet cell treatments for type 1 diabetes

    Dr Lise Hunault, a researcher in the Centenary Institute’s Centre for Biomedical AI, has been awarded a major research grant from Breakthrough T1D, the leading global type 1 diabetes research and advocacy organisation, to advance islet-cell replacement therapies for type 1 diabetes.
    News Type: Research News
    Date 16 Mar 2026
  • Centenary marks International Women’s Day with inspiring speakers

    The Centenary Institute community came together to celebrate International Women’s Day 2026, with a special event highlighting this year’s Australian theme, ‘Balancing the Scales.’
    News Type: Community
    Date 11 Mar 2026
  • Vaxosome launched to develop next-generation mRNA vaccines

    A new biotechnology company, Vaxosome, has been launched to develop next-generation vaccines aimed at tackling some of the world’s most challenging infectious diseases.
    News Type: Research News
    Date 10 Mar 2026
  • Centenary partners in transformative national liver health program

    The Snow Medical Research Foundation has today announced major long-term funding of $15.5 million for a new national research program targeting fatty liver disease, a condition that affects up to one in three Australians. The Centenary Institute will play a key role in the collaborative effort.
    News Type: Research News
    Date 05 Mar 2026

Subscribe to receive news on
research updates and free events

Newsletter

The Centenary Institute is a world-leading independent Medical Research Institute.

We acknowledge the Gadigal of the Eora Nation, the traditional custodians of the Country on which the Centenary Institute stands.

About

  • About us
  • Governance
  • Corporate information

Research

  • Our researchers
  • News

Careers & studies

  • Career opportunities
  • Student opportunities
  • Life at Centenary

Links

  • Contact
  • Privacy statement
  • Staff Intranet

Contact us

Building 93, Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050 Australia
Telephone +61 2 9565 6100
Fax +61 2 9565 6101

Contact Privacy

Centenary Institute ABN 22 654 201 090 (DGR 1) • Centenary Institute Medical Research Foundation ABN 85 778 244 012 (DGR 2)
© 2017 Centenary Institute of Cancer Medicine and Cell Biology.

  • Linkedin
  • Facebook
  • Twitter
  • Youtube
  • Instagram